This provider's $4.2M in total Medicare payments ranks in the 99th percentile of Diagnostic Radiology providers nationally.
Medicare payments to this provider grew 794% from 2014 to 2023.
71% of their billing comes from a single procedure code (78815 — Nuclear medicine study with CT imaging skull base to mid-thigh).
AI-generated analysis based on Medicare payment data.
Notable: Payments increased 275% in 2020
Year-over-year payment surges can indicate changes in practice volume, new services, or billing pattern shifts.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2014 | $2.8K | $367.36 | 7.74x | $2.5K | $124.5K | 403 | 376 |
| 2015 | $3.5K | $498.22 | 6.99x | $3.0K | $230.5K | 518 | 480 |
| 2016 | $3.1K | $492.81 | 6.25x | $2.6K | $446.1K | 867 | 841 |
| 2017 | $1.3K | $374.94 | 3.45x | $918.16 | $354.3K | 851 | 827 |
| 2018 | $2.0K | $473.23 | 4.29x | $1.6K | $156.0K | 340 | 337 |
| 2019 | $2.1K | $478.74 | 4.47x | $1.7K | $67.0K | 114 | 114 |
| 2020 | $1.5K | $458.32 | 3.21x | $1.0K | $251.2K | 788 | 668 |
| 2021 | $1.2K | $441.94 | 2.73x | $763.20 | $547.3K | 1.3K | 1.1K |
| 2022 | $2.3K | $746.05 | 3.10x | $1.6K | $893.5K | 2.1K | 1.9K |
| 2023 | $1.7K | $565.06 | 3.00x | $1.1K | $1.1M | 3.4K | 3.0K |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| 78815 | Nuclear medicine study with CT imaging skull base to mid-thigh | 3.1K | $3.0M | $958.24 | 3.35x |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 2.5K | $472.0K | $188.94 | 6.38x |
| 78816 | Nuclear medicine study with CT imaging whole body | 286 | $273.3K | $955.75 | 3.13x |
| A9596 | Gallium ga-68 gozetotide, diagnostic, (illuccix), 1 millicurie | 162 | $142.7K | $880.70 | 3.55x |
| 78431 | Multiple nuclear medicine studies of blood flow in heart muscle at rest and with stress, with concurrently acquired ct transmission scan | 1.6K | $109.6K | $69.98 | 4.29x |
| 78492 | Nuclear medicine study heart muscle at rest and/or stress multiple studies | 1.4K | $99.7K | $72.64 | 4.13x |
| 78434 | Nuclear medicine study of heart muscle blood flow by pet | 1.5K | $35.8K | $23.22 | 12.92x |
| A9597 | Positron emission tomography radiopharmaceutical, diagnostic, for tumor identification, not otherwise classified | 11 | $31.5K | $2.9K | 3.50x |
| A9595 | Piflufolastat f-18, diagnostic, 1 millicurie | 39 | $26.2K | $670.74 | 2.63x |
| A9580 | Sodium fluoride f-18, diagnostic, per study dose, up to 30 millicuries | 34 | $6.4K | $189.43 | 10.61x |
| 78306 | Bone and/or joint imaging, whole body | 12 | $2.8K | $231.01 | 3.14x |
| 79101 | Radioactive drug therapy through a vein | 11 | $1.3K | $115.75 | 3.12x |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | 11 | $683.76 | $62.16 | 3.99x |
| A9503 | Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries | 12 | $453.40 | $37.78 | 1.32x |
This provider submits charges 3.81 times higher than what Medicare actually pays.
A markup ratio of 3.81x means for every $100 Medicare pays, this provider initially charges $381. This is higher than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data